checkedPsychopharmacology and Psychiatry Updates2026-11-18last verified 2026-11-18

does the label give aripiprazole a 2-5 mg start and a 15 mg/day maximum as an add-on for depression

verdict: confirmed
the primary source says it, at that magnitude
“The labeled adjunctive dose starts at 2-5 mg a day. The maximum is 15 mg a day.”

a host said on Psychopharmacology and Psychiatry Updates, 2026-11-18, at 08:18. hear it in context → the speaker cited: the label.

the episode: Which Adjunctive Antipsychotic Is Best for Major Depression? (at 08:18). we link the show's own page; we do not re-host audio.

first, the part that holds

the speaker has it right. the current u.s. label for aripiprazole in adjunctive major depressive disorder gives a starting dose of 2 to 5 mg/day and a maximum of 15 mg/day, word for word.

what we found when we went and looked

we read two current u.s. labels on dailymed: the reference-brand aripiprazole tablet label (revised january 2025) and a generic aripiprazole tablet label (revised december 2023). both say "the recommended starting dose ... as adjunctive treatment for patients already taking an antidepressant is 2 to 5 mg/day" and "the recommended dosage range is 2 to 15 mg/day." the highlights dosing table in both labels lists adjunctive mdd as initial 2 to 5 mg/day, recommended 5 to 10 mg/day, maximum 15 mg/day. the label also adds two details the quote leaves out: doses go up by no more than 5 mg/day at a time, at least one week apart, and the usual target is 5 to 10 mg/day, not 15.

assertion by assertion

assertionverdictwhat the record says
the fda label gives a starting dose of 2 to 5 mg/day for aripiprazole as an add-on to an antidepressant in major depressive disorderconfirmedsection 2.3 of the reference-brand label (revised 1/2025) reads: "the recommended starting dose ... as adjunctive treatment for patients already taking an antidepressant is 2 to 5 mg/day." a generic label (revised 12/2023) has the same text, and both highlights tables list the initial dose as 2 to 5 mg/day. the label covers adults only. [1][2]
the fda label gives a maximum of 15 mg/day for this useconfirmedthe highlights dosing table lists the maximum dose for adults taking it as an add-on to antidepressants as 15 mg/day. section 2.3 gives the recommended range as 2 to 15 mg/day. both labels agree. [1][2]
context: what the label says between the starting dose and the maximumconfirmedthe highlights table lists a recommended dose of 5 to 10 mg/day. section 2.3 says dose increases of up to 5 mg/day "should occur gradually, at intervals of no less than one week." the quote skips this middle step, but that does not make it wrong. [1][2]
context: whether the dose changes when the antidepressant also blocks cyp2d6confirmedsection 2.7 of the generic label and section 2.6 of the brand label say that when aripiprazole is given as an add-on in mdd, it should be given "without dosage adjustment" and dosed as in section 2.3. that covers antidepressants that block cyp2d6, a liver enzyme that breaks down aripiprazole. for this use, the 2 to 15 mg/day range already allows for that. [1][2]

both directions

for the speaker: two separate u.s. labels say it the same way: the reference-brand tablet label (revised 1/2025) and a generic tablet label (revised 12/2023). in both, section 2.3 gives a starting dose of 2 to 5 mg/day and a range of 2 to 15 mg/day, and the highlights table lists 15 mg/day as the maximum for adults taking it as an add-on to antidepressants. the speaker named the label as the source, and the label is where these numbers come from.

against: nothing in the label contradicts the quote. a listener could still come away with an incomplete picture. the label's recommended dose is 5 to 10 mg/day, so 15 mg/day is a ceiling, not a typical dose. increases are capped at 5 mg/day, at least one week apart. the dosing applies to adults already taking an antidepressant, and the quote does not mention any of these points.

what this cannot say

a label is a regulatory document. it says what the fda approved for dosing, not what dose a given person does best on or what prescribers actually do. we read the u.s. tablet labels only. we did not check other forms of the drug (oral solution, dissolving tablet or film, long-acting injection), labels outside the u.s., or every generic version, though generic labels have to match the reference label on dosing. our fetch tool read the dosing sections and highlights of each label but not the full text of these very long documents. we did not check the trial data behind the dose range.

the medication pages behind this check

sources, each one fetched and read

  1. u.s. national library of medicine, dailymed: aripiprazole tablets, reference-brand prescribing information (otsuka america pharmaceutical), revised 1/2025 What we read there: section 2.3: "the recommended starting dose ... as adjunctive treatment for patients already taking an antidepressant is 2 to 5 mg/day. the recommended dosage range is 2 to 15 mg/day. dosage adjustments of up to 5 mg/day should occur gradually, at intervals of no less than one week." highlights table, mdd adjunct row: initial 2 to 5 mg/day, recommended 5 to 10 mg/day, maximum 15 mg/day. Fetched 2026-11-18 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c040bd1d-45b7-49f2-93ea-aed7220b30ac
  2. u.s. national library of medicine, dailymed: aripiprazole tablets, generic prescribing information (preferred pharmaceuticals inc.), revised 12/2023 What we read there: highlights table row "major depressive disorder – adults: adjunct to antidepressants": initial 2 to 5 mg/day, recommended 5 to 10 mg/day, maximum 15 mg/day. section 2.3: "the recommended dosage range is 2 to 15 mg/day." section 2.7: for adjunctive mdd, "aripiprazole should be administered without dosage adjustment" as specified in section 2.3. Fetched 2026-11-18 (HTTP 200). https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=34127431-6ad7-402f-bc22-1429c55d921c&type=display

speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam